Michael Doubek

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Peter Hillmen, Tadeusz Robak, Ann Janssens et al. · The Lancet · 2015 · 337 citations

Hematological Malignancy, Immunohematology, Complement 1 +13

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

Leila Noetzli, Richard Lo, Alisa B. Lee‐Sherick et al. · Nature Genetics · 2015 · 322 citations · Full text

Hematological Malignancy, Medicine, Pathogenesis +8

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis et al. · Leukemia · 2015 · 235 citations · Full text

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani et al. · Leukemia · 2018 · 233 citations · Full text